Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.4 million versus the consensus estimate of $43.94 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.